When it comes to breast carcinoma models, our previous study was the first report to show the time dependent increase in endogenous IL-33 in primary 4T1 mammary tumors in BALB/c mice during cancer progression, as assessed by increased IL-33 mRNA and protein levels accompanied with the time-dependent increase in ST2 mRNA levels [54]. This evidence concerns the gene IL33 and breast cancer.